| Remodulin Induction Facilitates Rapid Achievement of Therapeutic Doses of Oral Treprostinil: Results From the EXPEDITE Study JF Kingrey, CE Miller, V Balasubramanian, R Zolty, RJ Oudiz, JM Elwing, ... B97. RISKY BUSINESS: TREATMENTS AND CLINICAL TARGETS IN PULMONARY …, 2023 | 2 | 2023 |
| Optimization of Benzoxazinorifamycins to Minimize hPXR Activation for the Treatment of Tuberculosis and HIV Coinfection SR Ashkar, W Rajeswaran, PH Lee, L Yeomans, CM Thrasher, ... ACS Infectious Diseases 8 (8), 1408-1421, 2022 | 2 | 2022 |
| Expanded Use of Sodium Glucose Co‐Transporter 2 Inhibitors: Evidence Beyond Heart Failure with Reduced Ejection Fraction EM Schoenborn, PT Skersick, CM Thrasher, RL Page Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023 | 1 | 2023 |
| Universal Definition and Classification of Heart Failure: Pharmacists’ Perspective: Optimizing Guideline-Directed Medical Therapy and Educating Stakeholders C Thrasher, JH Patterson, M Fiuzat Journal of Cardiac Failure 27 (12), 1310-1312, 2021 | 1 | 2021 |
| Parenteral treprostinil induction for rapid attainment of therapeutic doses of oral treprostinil CE Miller, V Franco, JS Smith, V Balasubramanian, J Kingrey, R Zolty, ... Respiratory Medicine 218, 107374, 2023 | | 2023 |
